losartan has been researched along with Intracranial Hypertension in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Intracranial Hypertension: Increased pressure within the cranial vault. This may result from several conditions, including HYDROCEPHALUS; BRAIN EDEMA; intracranial masses; severe systemic HYPERTENSION; PSEUDOTUMOR CEREBRI; and other disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernandes, MV | 1 |
| Rosso Melo, M | 1 |
| Mowry, FE | 1 |
| Lucera, GM | 1 |
| Lauar, MR | 1 |
| Frigieri, G | 1 |
| Biancardi, VC | 1 |
| Menani, JV | 1 |
| Colombari, DSA | 1 |
| Colombari, E | 1 |
1 other study available for losartan and Intracranial Hypertension
| Article | Year |
|---|---|
Intracranial Pressure During the Development of Renovascular Hypertension.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood-Brain Barrier; Disease Models, Animal; Hyper | 2021 |